Table 4 Treatment of hyponatraemia according to treating team’s working diagnosis. Patients with multiple diagnoses have been omitted. Patients with multiple treatment modalities have been counted under each treatment
SIADH | Hypervolaemia | Non renal salt wasting | No diagnosis | Polydipsia | |
|---|---|---|---|---|---|
N (%) | 24 (15.8) | 25 (16.4) | 29 (19.1) | 48 (31.6) | 8 (5.3) |
Fluid Restriction | 17 (70.8) | 17 (68) | 1 (4) | 6 (12.5) | 4 (50) |
0.9% saline | 1 (4.2) | 1 (4) | 23 (92) | 7 (14.6) | 2 (25) |
3% saline | 2 (8.3) | 0 (0) | 0 (0) | 1 (2.1) | 3 (37.5) |
Fludrocortisone | 1 (4) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
No Treatment | 2 (8) | 2 (8) | 1 (4) | 32 (66.7) | 1 (12.5) |
0.9% saline ceased | 1 (4) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Urea | 5 (20) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Frusemide | 0 (0) | 9 (36) | 0 (0) | 1 (2.1) | 0 (0) |
Dialysis | 0 (0) | 1 (4) | 0 (0) | 0 (0) | 0 (0) |
Diuretics ceased | 0 (0) | 0 (0) | 0 (0) | 2 (4.2) | 0 (0) |
ACE inhibitor or Angiotensin II receptor blocker ceased | 0 (0) | 0 (0) | 0 (0) | 2 (4.2) | 0 (0) |